Highlights

News   Royalty ups bid as Elan unveils acquisitions Royalty ups bid as Elan unveils acquisitions Takeda's diabetes drug fasiglifam shines in Phase III Takeda's diabetes drug fasiglifam shines in Phase III Read more...